BRPI0518405A2 - detecÇço de vÍrus papiloma humano (hpv) utilizando sondas de Ácido nuclÉico, microcontas e separador de cÉlulas ativado fluorescente (facs) - Google Patents

detecÇço de vÍrus papiloma humano (hpv) utilizando sondas de Ácido nuclÉico, microcontas e separador de cÉlulas ativado fluorescente (facs)

Info

Publication number
BRPI0518405A2
BRPI0518405A2 BRPI0518405-3A BRPI0518405A BRPI0518405A2 BR PI0518405 A2 BRPI0518405 A2 BR PI0518405A2 BR PI0518405 A BRPI0518405 A BR PI0518405A BR PI0518405 A2 BRPI0518405 A2 BR PI0518405A2
Authority
BR
Brazil
Prior art keywords
detection
hpv
facs
nucleic acid
activated cell
Prior art date
Application number
BRPI0518405-3A
Other languages
English (en)
Inventor
Karl Poetter
Toby Gould
Original Assignee
Genera Biosystems Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2004907070A external-priority patent/AU2004907070A0/en
Application filed by Genera Biosystems Pty Ltd filed Critical Genera Biosystems Pty Ltd
Publication of BRPI0518405A2 publication Critical patent/BRPI0518405A2/pt
Publication of BRPI0518405B1 publication Critical patent/BRPI0518405B1/pt
Publication of BRPI0518405B8 publication Critical patent/BRPI0518405B8/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/708—Specific hybridization probes for papilloma

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

DETECÇçO DE VíRUS PAPILOMA HUMANO (HPV) UTILIZANDO SONDAS DE ÁCIDO NUCLÉICO, MICROCONTAS E SEPARADOR DE CÉLULAS ATIVADO FLUORESCENTE (FACS). A presente invenção refere-se genericamente ao campo de ensaios de detecção e diagnóstico. Mais particularmente, a presente invenção provê métodos e reagentes incluindo biochips para detectar a presença de, ou distinguir entre um ou mais analisados em uma amostra.
BRPI0518405A 2004-12-10 2005-12-09 conjunto de esferas para detectar uma cepa de hpv e/ou para diferenciar entre duas ou mais cepas de hpv, método para preparar o conjunto de esferas, método para diagnosticar infecção por hpv em um sujeito humano, uso do conjunto de esferas e método para detectar e/ou para diferenciar entre duas ou mais cepas de hpv particulares em uma amostra biológica BRPI0518405B8 (pt)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
AU2004907070 2004-12-10
AU2004907070A AU2004907070A0 (en) 2004-12-10 Compositions and methods of detection
US70497405P 2005-08-03 2005-08-03
US60/704,974 2005-08-03
PCT/AU2005/001865 WO2006060872A1 (en) 2004-12-10 2005-12-09 Human papilloma virus (hpv) detection using nucleic acid probes, microbeads and fluorescent-activated cell sorter (facs)

Publications (3)

Publication Number Publication Date
BRPI0518405A2 true BRPI0518405A2 (pt) 2008-11-18
BRPI0518405B1 BRPI0518405B1 (pt) 2021-01-05
BRPI0518405B8 BRPI0518405B8 (pt) 2021-07-27

Family

ID=36577611

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0518405A BRPI0518405B8 (pt) 2004-12-10 2005-12-09 conjunto de esferas para detectar uma cepa de hpv e/ou para diferenciar entre duas ou mais cepas de hpv, método para preparar o conjunto de esferas, método para diagnosticar infecção por hpv em um sujeito humano, uso do conjunto de esferas e método para detectar e/ou para diferenciar entre duas ou mais cepas de hpv particulares em uma amostra biológica

Country Status (9)

Country Link
US (2) US7901883B2 (pt)
EP (1) EP1833985B1 (pt)
JP (1) JP4974899B2 (pt)
AU (1) AU2005313858B2 (pt)
BR (1) BRPI0518405B8 (pt)
CA (1) CA2589912C (pt)
MX (1) MX2007006845A (pt)
NZ (1) NZ554229A (pt)
WO (1) WO2006060872A1 (pt)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100227315A1 (en) * 2004-05-26 2010-09-09 Paul Mulvaney Biosensor Using Whispering Gallery Modes in Microspheres
JP4974899B2 (ja) * 2004-12-10 2012-07-11 ジェネラ バイオシステムズ リミテッド 組成物および検出方法
JP2008196927A (ja) * 2007-02-13 2008-08-28 Fujifilm Corp プローブの脱着を伴う対象物質の検出方法
US8278429B2 (en) 2007-04-05 2012-10-02 Genera Biosystems Limited Oligonucleotide amplification primers for targeting oncogenic HPV
WO2008137530A1 (en) * 2007-05-03 2008-11-13 One Lambda, Inc. Methods of screening for binding interaction using sets of microparticles and unique probes
CN101487042B (zh) * 2008-01-18 2012-05-30 中山大学达安基因股份有限公司 Hpv高危和低危亚型分型dna微阵列芯片
US8658417B2 (en) * 2009-09-15 2014-02-25 Qiagen Gaithersburg, Inc. Multiple-input analytical system
US20140330131A1 (en) * 2011-05-13 2014-11-06 Adelaide Research & Innovation Pty Ltd. Method of and a system for characterising a material
AU2013201420B2 (en) * 2011-10-04 2015-12-24 Genera Biosystems Limited An assay
CN104459975B (zh) * 2014-12-29 2016-08-24 中国科学院长春光学精密机械与物理研究所 成像流式细胞仪的显微成像光学系统
WO2021041874A1 (en) 2019-08-29 2021-03-04 Martin David C Biofunctional thiophene monomers
WO2022140549A1 (en) * 2020-12-22 2022-06-30 Poppy Health, Inc. System and method for detecting pathogens in an environment
CN113189059B (zh) * 2021-01-07 2023-03-28 西安交通大学 基于适配体和声表面波的病毒分选富集检测系统及方法
US11543332B2 (en) * 2021-04-23 2023-01-03 Poppy Health, Inc. System and method for characterizing, monitoring, and detecting bioaerosol presence and movement in an indoor environment
US12181401B2 (en) 2021-12-07 2024-12-31 Poppy Health, Inc. Tracer detection system and method for characterizing effectiveness of air removal in an aerosol zone
US12540933B2 (en) 2021-12-07 2026-02-03 Poppy Health, Inc. System and method for characterizing, monitoring, and detecting bioaerosol presence and movement in an indoor environment
EP4435045A1 (en) * 2023-03-21 2024-09-25 COSA Group GmbH Labelled particles

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5411857A (en) 1985-07-31 1995-05-02 Institut Nationale De La Sante Probes for papillomaviruses and an in vitro diagnostic procedure for papilloma infections
CA1276575C (fr) 1984-11-30 1990-11-20 Sylvie Beaudenon Sondes a papillomavirus et procede de diagnostic in vitro d'infections a papillomavirus
US5876922A (en) 1985-07-31 1999-03-02 Institute Pasteur Papillomavirus probe and a process for in vitro diagnosis of papillomavirus infections
ATE76429T1 (de) 1986-03-21 1992-06-15 Pasteur Institut Bestimmte, von einem papillomavirus-genom abgeleitete dns-sequenzen, deren anwendungen fuer in vitro-diagnostische zwecke und die herstellung von antigenzusammensetzungen.
AU619170B2 (en) 1987-01-09 1992-01-23 Abbott Laboratories Diagnostic assays using nucleic acid probes
FR2629458B2 (fr) 1987-07-31 1991-08-09 Ire Celltarg Sa Nouvelles sondes d'acides nucleiques specifiques de differents types de virus de papillome humain
US5639871A (en) 1988-09-09 1997-06-17 Roche Molecular Systems, Inc. Detection of human papillomavirus by the polymerase chain reaction
US5447839A (en) 1988-09-09 1995-09-05 Hoffmann-La Roche Inc. Detection of human papillomavirus by the polymerase chain reaction
CA1339729C (en) 1988-10-26 1998-03-17 Wayne D. Lancaster Human papillomavirus type 52 dna sequences and methods for employing thesame
US5580970A (en) 1989-12-01 1996-12-03 Amoco Corporation Detection of HPV transcripts
NL9000134A (nl) 1990-01-19 1991-08-16 Stichting Res Fonds Pathologie Primers en werkwijze voor het detecteren van humaan papilloma virus genotypen m.b.v. pcr.
US5484699A (en) 1990-09-28 1996-01-16 Abbott Laboratories Nucleotide sequences useful as type specific probes, PCR primers and LCR probes for the amplification and detection of human papilloma virus, and related kits and methods
FR2670797A1 (fr) 1990-12-20 1992-06-26 Pasteur Institut Sequences d'adn determinees derivees du genome du papillomavirus hpv39, application de ces sequences au diagnostic in vitro d'infection par ce papillomavirus, et a la production de composition immunogene.
US5346811A (en) 1991-07-22 1994-09-13 Cerveceria Polar Method and products for human papillomavirus detection
ES2181765T3 (es) * 1994-02-21 2003-03-01 Stichting Res Fonds Pathologie Deteccion de papiloma virus humano en un proceso de amplificacion de acido nucleico utilizando cebadores generales.
CA2163393C (en) 1994-11-30 2003-04-22 Colleen Marie Nycz Amplification and detection of mycobacteria nucleic acids
WO1997014028A2 (en) 1995-10-11 1997-04-17 Luminex Corporation Multiplexed analysis of clinical specimens apparatus and method
US5981180A (en) * 1995-10-11 1999-11-09 Luminex Corporation Multiplexed analysis of clinical specimens apparatus and methods
AU726047B2 (en) 1995-11-15 2000-10-26 Gen-Probe Incorporated Nucleic acid probes complementary to human papillomavirus nucleic acid and related methods and kits
US6511805B1 (en) 1996-03-15 2003-01-28 The Penn State Research Foundation Methods for detecting papillomavirus DNA in blood plasma and serum
US6265154B1 (en) 1996-10-25 2001-07-24 Abbott Laboratories Nucleic acid primers and probes for detecting oncogenic human papillomaviruses
WO1999014377A2 (en) 1997-09-16 1999-03-25 Innogenetics N.V. Detection and identification of human papillomavirus by pcr and type-specific reverse hybridization
ZA989950B (en) 1997-11-17 1999-05-04 Akzo Nobel Nv Transcription based amplification of double stranded DNA targets
AU2001294648A1 (en) * 2000-09-22 2002-04-02 Luminex Corporation Multiple reporter read-out for bioassays
WO2002039083A2 (en) * 2000-11-08 2002-05-16 Science & Technology Corporation @ Unm Fluorescence and fret based assays for biomolecules on beads
AU2002237662A1 (en) 2000-11-17 2002-05-27 Surromed, Inc. Analysis of soluble factor biological markers
ES2276948T3 (es) 2001-08-23 2007-07-01 MERCK & CO., INC. Ensayos pcr de hp multiplex fluorescente que usan fluoforos multiples.
KR100452163B1 (ko) * 2001-09-14 2004-10-12 주식회사 바이오메드랩 인유두종 바이러스의 감염을 진단하기 위한 유전형 분석키트
US20030224385A1 (en) * 2001-12-07 2003-12-04 German Pihan Targeted genetic risk-stratification using microarrays
AU2002950953A0 (en) 2002-08-23 2002-09-12 Genera Biosystems Pty Ltd Coded nucleic acid carriers
KR100541916B1 (ko) 2003-03-24 2006-01-10 바이오코아 주식회사 인유두종바이러스(ｈｐｖ)유전자형 분석용 서스펜션어레이 마이크로스피어 비드 조성물 및 그 검사 방법
AU2003903417A0 (en) * 2003-07-04 2003-07-17 Genera Biosystems Pty Ltd Multiplex detection
JP4974899B2 (ja) * 2004-12-10 2012-07-11 ジェネラ バイオシステムズ リミテッド 組成物および検出方法

Also Published As

Publication number Publication date
MX2007006845A (es) 2007-10-23
EP1833985B1 (en) 2014-08-27
JP4974899B2 (ja) 2012-07-11
US20110123978A1 (en) 2011-05-26
US20100015594A1 (en) 2010-01-21
CA2589912C (en) 2019-03-05
EP1833985A4 (en) 2009-07-29
BRPI0518405B8 (pt) 2021-07-27
JP2008522592A (ja) 2008-07-03
WO2006060872A1 (en) 2006-06-15
US7901883B2 (en) 2011-03-08
AU2005313858B2 (en) 2011-04-07
EP1833985A1 (en) 2007-09-19
CA2589912A1 (en) 2006-06-15
US8389217B2 (en) 2013-03-05
AU2005313858A1 (en) 2006-06-15
BRPI0518405B1 (pt) 2021-01-05
NZ554229A (en) 2009-03-31

Similar Documents

Publication Publication Date Title
BRPI0518405A2 (pt) detecÇço de vÍrus papiloma humano (hpv) utilizando sondas de Ácido nuclÉico, microcontas e separador de cÉlulas ativado fluorescente (facs)
WO2015070037A3 (en) Polynucleotide conjugates and methods for analyte detection
Singh et al. Detection and disinfection of COVID-19 virus in wastewater
RU2713112C2 (ru) Способы и средства для диагностики гриппа
DK1766400T3 (da) Fremgangsmåde til at udföre fuldblodsanalyser
BR112014010718A2 (pt) métodos e sistemas para detecção de analito em amostra
EP3460060A3 (en) Scalable bio-element analysis
WO2006076567A3 (en) Microfluidic rare cell detection device
BRPI0809138B8 (pt) método para detectar a presença ou quantidade de um ou mais analitos em uma amostra biológica
Meng et al. Applications of laboratory findings in the prevention, diagnosis, treatment, and monitoring of COVID-19
EA200971124A1 (ru) Множественный анализ образцов крови
WO2010141075A8 (en) Specific analysis of ketone and aldehyde analytes using reagent compounds, labeling strategies, and mass spectrometry workflow
EP1979000A4 (en) METHOD FOR DETECTING CANCER CELLS USING A VIRUS
EP4524571A3 (en) Assay for jc virus antibodies
WO2007133586A3 (en) Systems and methods for developing diagnostic tests based on biomarker information from legacy clinical sample sets
TW200720441A (en) New labelling strategies for the sensitive detection of analytes
WO2005030041A3 (en) Detection of hpv
MX2009010751A (es) Composiciones y metodos de deteccion.
WO2017070419A1 (en) Mxa to drive increased specificity and augment sensitivity of bacterial biomarkers
MX2010003116A (es) Identificacion y aislamiento de celulas fetales y acido nucleico.
SG170051A1 (en) T cell assays
IL177693A0 (en) Method, chip, device and integrated system for detection biological particles
Zhu et al. Enhancing point-of-care diagnosis of African swine fever virus (ASFV) DNA with the CRISPR-Cas12a-assisted triplex amplified assay
EP2520669A3 (en) Mild osteoathritis biomarkers and uses thereof
WO2008152528A3 (en) Method for the diagnosis or the screening of an arbovirus infection, reagents useful in said method and their applications

Legal Events

Date Code Title Description
B25D Requested change of name of applicant approved

Owner name: GENERA BIOSYSTEMS LIMITED (AU)

Free format text: ALTERADO DE: GENERA BIOSYSTEMS PTY LTD.

B25G Requested change of headquarter approved

Owner name: GENERA BIOSYSTEMS LIMITED (AU)

Free format text: SEDE ALTERADA CONFORME SOLICITADO NA PETICAO NO 020090101611/RJ DE 29/10/2009.

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 05/01/2021, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 09/12/2005, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF, QUE DETERMINA A ALTERACAO DO PRAZO DE CONCESSAO

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 16A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2648 DE 05-10-2021 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.